{
    "id": 29546,
    "fullName": "ACTG2 - ALK",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ACTG2-ALK results from the fusion of ACTG2 and ALK (PMID: 30518629). ACTG2-ALK has been identified in leiomyosarcoma (PMID: 30518629), but has not been biochemically characterized and therefore, the effect on protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 14378,
                    "pubMedId": 30518629,
                    "title": "Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30518629"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 72,
        "geneSymbol": "ACTG2",
        "terms": [
            "ACTG2",
            "ACT",
            "ACTA3",
            "ACTE",
            "ACTL3",
            "ACTSG",
            "VSCM"
        ]
    },
    "variant": "ACTG2 - ALK",
    "createDate": "03/12/2019",
    "updateDate": "10/17/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 31596,
            "profileName": "ACTG2 - ALK",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}